Modest dose anti-thymocyte globulin administered intraoperatively is safe and effective in kidney transplantations: a retrospective study

BACKGROUND: Anti-thymocyte globulin (ATG) as induction therapy in renal transplantation is facing the dilemma of reducing the incidence of acute rejection (AR) and delayed graft function (DGF) or increasing risks of infection and malignancy. The purpose of this study was to delineate the safety and...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Hui-Ying, Cheng, Yuan-Tso, Luo, Hao Lun, Huang, Chiang-Chi, Chen, Chien Hsu, Shen, Yuan-Chi, Lee, Wen-Chin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2019
Materias:
Nephrology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6699478/
https://www.ncbi.nlm.nih.gov/pubmed/31440428
http://dx.doi.org/10.7717/peerj.7274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6699478/
https://www.ncbi.nlm.nih.gov/pubmed/31440428
http://dx.doi.org/10.7717/peerj.7274

Ejemplares similares